Evidence map›Paper›PMID 20212171›Full record

ArticleBlood2010

C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies.

Alfonso Buil, David-Alexandre Trégouët, Juan Carlos Souto, Noémie Saut, Marine Germain, Maxime Rotival, Laurence Tiret, Françcois Cambien, Mark Lathrop, Tanja Zeller and 11 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. C4b-binding protein as an antigenic target in the pathogenesis of antiphosphatidylethanolamine autoantibodies.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Identification of multiple novel procoagulant plasma ligands for stabilin-2.Journal of thrombosis and haemostasis : JTH · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Genetic association study of fatal pulmonary embolism.International journal of legal medicine · 2021
    Article
  15. Article
  16. Article
  17. Effects of miR-101-3p on goat granulosa cellsJournal of animal science and biotechnology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 5 countries.

Alfonso BuilUnitat de Genómica de Malalties Complexes, Institut de Recerca Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
David-Alexandre Trégouët
Juan Carlos Souto
Noémie Saut
Marine Germain
Maxime Rotival
Laurence Tiret
Françcois Cambien
Mark Lathrop
Tanja Zeller
Marie-Christine Alessi
Santiago Rodriguez de Cordoba
Thomas Münzel
Philipp Wild
Jordi Fontcuberta
France Gagnon
Joseph Emmerich
Laura Almasy
Stefan Blankenberg
José-Manuel Soria
Pierre-Emmanuel Morange
Inserm · FRJohannes Gutenberg University Mainz · DEHospital de Sant Pau · ESSorbonne Université · FR3M (United States) · USConsejo Superior de Investigaciones Científicas · ESInstitut de Neurobiologie de la Méditerranée · FRSociedad Española de Trombosis y Hemostasia · ESTexas Biomedical Research Institute · US

Funding

Genetic Analysis of Idiopathic ThrombosisR01HL070751 · NHLBI · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI ALMASY, LAURA A. · 2002 to 2010
$3.7M
NHLBI NIH HHS 2 R01 HL070751-05NHLBI NIH HHS R01 HL070751
6 · The paper itself

Abstract

Through its binding with protein S (PS), a key element of the coagulation/fibrinolysis cascade, the C4b-binding protein (C4BP) has been hypothesized to be involved in the susceptibility to venous thrombosis (VT). To identify genetic factors that may influence the plasma levels of the 3 C4BP existing isoforms, alpha(7)beta(1), alpha(6)beta(1), and alpha(7)beta(0), we conducted a genome-wide association study by analyzing 283 437 single nucleotide polymorphisms (SNPs) in the Genetic Analysis of Idiopathic Thrombophilia (GAIT) study composed of 352 persons. Three SNPs at the C4BPB/C4BPA locus were found genome-wide significantly associated with alpha(7)beta(0) levels. One of these SNPs was further found to explain approximately 11% of the variability of mRNA C4BPA expression in the Gutenberg Heart Study composed of 1490 persons, with no effect on C4BPB mRNA expression. The allele associated with increased alpha(7)beta(0) plasma levels and increased C4BPA expression was further found associated with increased risk of VT (odds ratio [OR] = 1.24 [1.03-1.53]) in 2 independent case-control studies (MARseille THrombosis Association study [MARTHA] and FActeurs de RIsque et de récidives de la maladie thromboembolique VEineuse [FARIVE]) gathering 1706 cases and 1379 controls. This SNP was not associated with free PS or total PS. In conclusion, we observed strong evidence that the C4BPB/C4BPA locus is a new susceptibility locus for VT through a PS-independent mechanism that remains to be elucidated.

Indexed as

Case-Control StudiesGenetic LociPolymorphism, Single NucleotideClinical Trials as TopicComplement C4b-Binding ProteinFemaleGene Expression RegulationGenetic Predisposition to DiseaseGenome-Wide Association StudyHistocompatibility AntigensHumansMaleProtein SRisk FactorsVenous ThrombosisC4BPA protein, humanC4BPB protein, humanComplement C4b-Binding ProteinHistocompatibility AntigensProtein S

Identifiers

PMID20212171
PMCPMC2890187
OpenAlexW2024761240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.